- Effect of clinical parameters on second- and third-line erlotinib treatment of EGFR wild type patients with advanced NSCLC2019 | Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Atezolizumab in the first line of treatment for non-squamous metastatic non-small cell lung cancer2019 | Second Faculty of Medicine
- Atezolizumab in the treatment of lung cancer2020 | Publication without faculty affiliation